Combination therapy of TF-CAR-NK cells and L-ICON (or other therapeutic antibody) will be further studies in vivo in animal models of cancer when using TF-CAR-NK cells generated from healthy donors’ and cancer patients’ NK cells. The gene discussed is TF; the disease is cancer.